Growth Metrics

Zimmer Biomet Holdings (ZBH) Total Debt Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 157.11%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -12.26%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 5.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -2.48%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.12%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.70%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 15.70%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -5.48%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 4.11%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 4.11%
Dec 31, 2025 21.19%
Sep 30, 2025 25.76%
Jun 30, 2025 29.78%
Mar 31, 2025 23.81%
Dec 31, 2024 7.57%
Sep 30, 2024 17.66%
Jun 30, 2024 2.19%
Mar 31, 2024 0.11%
Dec 31, 2023 1.25%
Sep 30, 2023 -4.06%
Jun 30, 2023 -5.22%
Mar 31, 2023 -8.11%
Dec 31, 2022 -19.41%
Sep 30, 2022 -23.85%
Jun 30, 2022 -23.29%
Mar 31, 2022 -19.62%
Dec 31, 2021 -13.02%
Sep 30, 2021 -9.49%
Jun 30, 2021 -4.35%
Mar 31, 2021 -18.97%
Dec 31, 2020 -1.15%
Sep 30, 2020 -0.67%
Jun 30, 2020 -5.85%
Mar 31, 2020 9.80%
Dec 31, 2019 -8.02%
Sep 30, 2019 -9.26%
Jun 30, 2019 8,292.01%
Mar 31, 2019 440.83%
Dec 31, 2018 -11.87%
Sep 30, 2018 648.30%
Jun 30, 2018 -92.21%
Mar 31, 2018 -85.85%
Dec 31, 2017 1,649.31%
Sep 30, 2017 111.84%
Jun 30, 2017 164.32%
Mar 31, 2017 250,178.26%
Sep 30, 2016 157.87%
Jun 30, 2016 68.17%
Mar 31, 2016 -99.95%
Sep 30, 2015 -11.42%
Jun 30, 2015 -82.22%
Mar 31, 2015 439.33%
Dec 31, 2014 2,369.23%
Sep 30, 2014 -84.93%
Jun 30, 2014 -0.04%
Mar 31, 2014 -1.33%
Dec 31, 2013 -99.86%
Sep 30, 2013 -2.79%
Jun 30, 2013 -2.42%
Mar 31, 2013 -0.85%
Dec 31, 2012 5.92%
Sep 30, 2012 12.37%
Jun 30, 2012 50.78%
Mar 31, 2012 50.62%
Dec 31, 2011 50.51%
Sep 30, 2011 35.56%
Jun 30, 2011 1.48%
Mar 31, 2011 1.17%
Dec 31, 2010 1.29%
Sep 30, 2010 89.70%
Jun 30, 2010 73.01%